COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
22/03/2018
REGULATED INFORMATION GHENT, Belgium, 22 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
VALNEVA annonce la publication de son Document de Référence
22/03/2018
Valneva annonce la publication de son Document de Référence Lyon (France), 22 mars 2018 - Valneva SE ("Valneva" ou "Le Groupe"), société de biotechnologie dédiée au développement, à la production et à la [...]
argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117 for treatment of severe autoimmune diseases
22/03/2018
Potential for ARGX-117 to have synergistic effect with lead autoimmune compound ARGX-113 March 22, 2018 Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology [...]
Immutep Commences Patient Dosing in Additional TACTI-mel Cohort
21/03/2018
SYDNEY, Australia, March 21, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”) has announced the initiation of patient dosing in the new cohort of the TACTI-mel ( T wo ACT [...]
RavenQuest Begins Trading on Frankfurt Exchange Under Symbol “1IT”
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that it has commenced trading on [...]
MDxHealth (R): MDxHealth Launches Capital Increase
21/03/2018
Press release - Regulated information - Inside information - 21 March 2018, 5:45 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM - 21 March 2018 - MDxHealth SA (Euronext Brussels: MDXH) a world leader in molecular diagnostics [...]
MDxHealth (R) : MDxHealth lance une Augmentation de Capital
21/03/2018
Communiqué de presse - Information réglementée - Information privilégiée - 21 mars 2018, 17h45 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 21 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) un leader mondial dans les [...]
Recording of the Fourth Quarter 2017 Investor Conference Webinar
21/03/2018
Olaine, 2018-03-21 22:33 CET (GLOBE NEWSWIRE) -- The recorded AS “Olainfarm” webinar is available online: http://ej.uz/OLF_Q4_2017 , and the presentation, demonstrated during the webinar, is available in the attachment [...]
Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer
21/03/2018
WESTLAKE VILLAGE, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced the appointment of John W. Smither as the Company’s Chief Financial Officer. Mr. Smither will [...]
Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update
21/03/2018
WINNIPEG, Manitoba, March 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) is pleased to announce its 2017 Year End and Fourth Quarter Financial Results. [...]
Assure Holdings Corp. Announces Update
21/03/2018
PARKER, Colo., March 21, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services is providing the following update [...]
Cellectar Reports 2017 Financial Results and Provides a Corporate Update
21/03/2018
MADISON, Wis., March 21, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
TRACON Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
SAN DIEGO, March 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL
21/03/2018
U.S. Patent Issued Covering the Use of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for treating Posttraumatic Stress Disorder (PTSD) Patent Will Provide Intellectual Property Protection until at least 2030 for Use [...]
Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018
21/03/2018
CHARLESTON, S.C., March 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) will announce its fourth quarter and year ended December 31, 2017 financial and operating results after market [...]
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Solon Eiendom ASA : Primary insider notification
21/03/2018
(Oslo, Norway, 21 March 2018) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today rolled over a forward contract for [...]
Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Strategic Partnership with Madison Partners
21/03/2018
JERSEY CITY, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a strategic partnership and [...]

Pages